NO975790L - Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer - Google Patents

Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer

Info

Publication number
NO975790L
NO975790L NO975790A NO975790A NO975790L NO 975790 L NO975790 L NO 975790L NO 975790 A NO975790 A NO 975790A NO 975790 A NO975790 A NO 975790A NO 975790 L NO975790 L NO 975790L
Authority
NO
Norway
Prior art keywords
associated diseases
pylori infection
terbinafine
medicament
manufacture
Prior art date
Application number
NO975790A
Other languages
English (en)
Other versions
NO317496B1 (no
NO975790D0 (no
Inventor
Ivan James Dalton Lindley
Neil Stewart Ryder
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO975790D0 publication Critical patent/NO975790D0/no
Publication of NO975790L publication Critical patent/NO975790L/no
Publication of NO317496B1 publication Critical patent/NO317496B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
NO19975790A 1995-07-06 1997-12-09 Anvendelse av allylaminderivater for fremstillingen av et medikament for behandling av Helicobacter-pylori-infeksjon og beslektede sykdommer NO317496B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513750.1A GB9513750D0 (en) 1995-07-06 1995-07-06 Use of allylamines
PCT/EP1996/002970 WO1997002026A1 (en) 1995-07-06 1996-07-05 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Publications (3)

Publication Number Publication Date
NO975790D0 NO975790D0 (no) 1997-12-09
NO975790L true NO975790L (no) 1997-12-09
NO317496B1 NO317496B1 (no) 2004-11-08

Family

ID=10777201

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975790A NO317496B1 (no) 1995-07-06 1997-12-09 Anvendelse av allylaminderivater for fremstillingen av et medikament for behandling av Helicobacter-pylori-infeksjon og beslektede sykdommer

Country Status (27)

Country Link
US (1) US5935998A (no)
EP (1) EP0863752B1 (no)
JP (1) JP3680950B2 (no)
KR (1) KR100425401B1 (no)
CN (1) CN1204881C (no)
AT (1) ATE232723T1 (no)
AU (1) AU715270B2 (no)
CA (1) CA2219678C (no)
CY (1) CY2465B1 (no)
CZ (1) CZ289440B6 (no)
DE (1) DE69626301T2 (no)
DK (1) DK0863752T3 (no)
ES (1) ES2192608T3 (no)
GB (1) GB9513750D0 (no)
HK (1) HK1011527A1 (no)
HU (1) HU224311B1 (no)
IL (1) IL122853A (no)
MX (1) MX9710093A (no)
MY (1) MY132436A (no)
NO (1) NO317496B1 (no)
PL (1) PL187704B1 (no)
RU (1) RU2193402C2 (no)
SI (1) SI0863752T1 (no)
SK (1) SK282874B6 (no)
TW (1) TW522011B (no)
WO (1) WO1997002026A1 (no)
ZA (1) ZA965749B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) * 2002-02-05 2003-08-09 한솔케미언스 주식회사 (ｅ)-터비나핀 또는 이의 염산염의 제조방법
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE3020113A1 (de) * 1979-06-08 1980-12-18 Sandoz Ag 2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
DE4317449A1 (de) * 1993-05-19 1994-11-24 Asche Ag Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

Also Published As

Publication number Publication date
GB9513750D0 (en) 1995-09-06
HUP9802929A3 (en) 1999-10-28
EP0863752B1 (en) 2003-02-19
MX9710093A (es) 1998-03-31
ZA965749B (en) 1998-01-05
WO1997002026A1 (en) 1997-01-23
CN1204881C (zh) 2005-06-08
CN1189775A (zh) 1998-08-05
JPH11508580A (ja) 1999-07-27
NO317496B1 (no) 2004-11-08
IL122853A0 (en) 1998-08-16
AU715270B2 (en) 2000-01-20
RU2193402C2 (ru) 2002-11-27
ATE232723T1 (de) 2003-03-15
PL323305A1 (en) 1998-03-16
SI0863752T1 (en) 2003-06-30
CZ1798A3 (cs) 1998-03-18
EP0863752A1 (en) 1998-09-16
CA2219678C (en) 2006-10-10
KR100425401B1 (ko) 2004-07-16
PL187704B1 (pl) 2004-09-30
HUP9802929A2 (hu) 1999-09-28
NO975790D0 (no) 1997-12-09
TW522011B (en) 2003-03-01
SK282874B6 (sk) 2003-01-09
DK0863752T3 (da) 2003-04-22
JP3680950B2 (ja) 2005-08-10
CZ289440B6 (cs) 2002-01-16
HU224311B1 (hu) 2005-07-28
DE69626301T2 (de) 2003-10-16
DE69626301D1 (de) 2003-03-27
IL122853A (en) 2001-04-30
AU6519596A (en) 1997-02-05
KR19990028725A (ko) 1999-04-15
CA2219678A1 (en) 1997-01-23
CY2465B1 (en) 2005-06-03
SK698A3 (en) 1998-05-06
ES2192608T3 (es) 2003-10-16
MY132436A (en) 2007-10-31
US5935998A (en) 1999-08-10
HK1011527A1 (en) 1999-07-16

Similar Documents

Publication Publication Date Title
NO960067L (no) Nytt farmasöytisk preparat
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
BR9611175B1 (pt) compostos e composiÇÕes farmacÊuticas.
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
CO5271691A1 (es) Nuevos compuestos
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
SE9401728D0 (sv) New compounds II
PT749308E (pt) Pastilha, revestida com filme, de paracetamol e domperidona
SE9700885D0 (sv) New pharmaceutical formulation
ATE360428T1 (de) Analgetisches arzneimittel
DE69516671D1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
NO975790D0 (no) Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer
BR9506956A (pt) Composição farmacêutica antitussígena
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
SE0001916D0 (sv) Novel formulation
BR9611276A (pt) Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto
SE9302218D0 (sv) New use
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
SE9604752D0 (sv) Formulation and use
BR9713044A (pt) Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
NO952308L (no) Anvendelse av ruluzoler som radiorestaurator
ES2062940A1 (es) Agente gastrocinetico, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
UA38697A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees